Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC

BSE5861.25-3.15 (-0.05 %)

PREV CLOSE ( ) 5864.40

OPEN PRICE ( ) 5864.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 887

TODAY'S LOW / HIGH ( )5830.00 5979.00

52 WK LOW / HIGH ( )4912.3 6107.55

NSE5854.00-5 (-0.09 %)

PREV CLOSE( ) 5859.00

OPEN PRICE ( ) 5857.00

BID PRICE (QTY) 5854.00 (76)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 15274

TODAY'S LOW / HIGH( ) 5830.00 5984.50

52 WK LOW / HIGH ( )4863 6175.5

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 26-04 1967

Management Info

Suresh N Talwar - Chairman Milind Thatte - Managing Director

Registered Office

Address Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (East),
Mumbai,
Maharashtra-400099

Phone 022 68669000

Email investorgrievance.im@pg.com

Website www.pghealthindia.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

17Jun Procter & Gamble Health informs about
With reference to the virtual connect with analysts/ institutional inves..

11Jun Procter & Gamble Health informs about
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

09Jun Procter & Gamble Health informs about
Procter & Gamble Health has informed that it attached Company's comm..

10Mar Procter & Gamble Health informs about
Procter & Gamble Health has submitted the notice of the Postal Ballo..

18Feb Procter & Gamble Health informs about
Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 24
Net Profit	611.8	2009.8
Gross Profit	785.3	2733.2
Operating Profit	840.3	3216.3
Net Sales	3109.9	11512.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

SMS Lifesciences (BSE) 1299.15 (13.58%)	M.Cap ( in Cr)392.77
RPG Life Sciences (BSE) 2645.50 (3.46%)	M.Cap ( in Cr)4375.40
Ajanta Pharma (BSE) 2786.30 (3.18%)	M.Cap ( in Cr)34804.26
Gland Pharma (BSE) 1970.75 (3.94%)	M.Cap ( in Cr)32469.37
NGL Fine-Chem (BSE) 1442.05 (5.00%)	M.Cap ( in Cr)890.90

Shareholding Pattern

	PROMOTERS	51.82%
	NON-INSTITUTION	27.11%
	MUTUAL FUNDS/UTI	10.54%
	FI/BANKS/INSURANCE	3.47%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
UTI MNC Fund-Reg(IDCW)	4.94
UTI Healthcare Fund...	4.30
Sundaram LT Tax Adv...	3.15
DSP Healthcare Fund...	3.06
Sundaram LT Tax Adv...	2.94
Sundaram LT Micro C...	2.91
Sundaram LT Micro C...	2.82

Risk Disclosures on Derivatives

Smart Quotes

PROCTER & GAMBLE HEALTH LTD.